Press Release
« Back
Globus Medical Announces Positive Clinical Results for Lateral Expandable Technology
May 15, 2018
The study co-authored by Joseph O’Brien, MD, orthopedic surgeon at
While no subsidence was found in patients treated with expandable LLIF spacers, implant subsidence occurred in 16% of levels treated with static LLIF spacers. “Subsidence is a greater concern with the minimally invasive LLIF technique since it relies heavily on indirect decompression of the neural elements as compared to alternative posterior approaches,” said Dr. O’Brien. “The ability to insert Globus’ expandable spacers with less impaction and to control height expansion from within the disc space helps to minimize endplate damage and in this study resulted in a reduced risk of implant subsidence.”
Access the full study and learn more about Globus Medical’s lateral expandable interbody spacers portfolio at www.GlobusMedical.com/LLIF
About
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the
Contact:
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com
Source: Globus Medical